Search

everythinglearnresearchcommunity

for

Search:↓

Human skin produces sex hormones like estrogen and testosterone, influenced by ARO and StAR, which may affect skin elasticity and hair growth.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Finasteride causes harmful organ changes in female mice.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Certain drugs can cause male infertility, so fertility counseling and sperm preservation are advised.

Angiopoietin-1 helps hair cells survive and grow, making it a potential treatment for hair loss.

High TNF-α levels may increase hair loss risk after PRP therapy.

Certain gene variations in AKT2 are more common in women with PCOS and are linked to higher levels of specific hormones and symptoms.